Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: U.S. Food and Drug Administration Last Updated: Mar 11, 2010 - 5:11:27 PM



FDA Issues Warning on Counterfeit Surgical Mesh

By U.S. Food and Drug Administration
Mar 11, 2010 - 5:09:19 PM



Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust


Email this article
 Printer friendly page
Counterfeit polypropylene mesh products marketed as C. R. Bard/Davol

(HealthNewsDigest.com) - The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists.

The warning is of particular significance to health care professionals and their patients with surgical mesh implants as well as hospitals and surgical centers, operating room medical professionals and staff, and purchasing and risk managers.

Investigations by the FDA and Bard show that the following products, sizes and lots of counterfeit flat sheet polypropylene surgical mesh are not manufactured by Bard. To date, four product sizes have been identified:

0112650 – Bard Flat Mesh 2”x 4” Lot 48HVS036
Lot 43APD007

0112660 – Bard Flat Mesh 10”x 14” Lot HUSD0629
Lot HURL0336

0112680 – Bard Flat Mesh 3”x 6” Lot 43HPD027
Lot 43HPD032
Lot HUSG0540
Lot 43HDP027
Lot HUSE0532
Lot 43LPD507
Lot HUSF0763
Lot 43IOD011
Lot 43IPD038

0112720 – Bard Flat Mesh 6” x 6” Lot 43FQD327

The FDA is recommending that health care professionals:

Do not use any counterfeit Bard surgical mesh from the lots listed
Carefully examine all manufacturers’ polypropylene surgical mesh products and packaging for lot numbers and anything unusual that might indicate counterfeit mesh

Contact Bard at 800-556-6275 if they think they have one of the counterfeit products
Contact the particular manufacturer if they notice anything unusual or suspicious with any other brand of surgical mesh product or packaging.

The FDA also recommends that health care professionals continue to monitor patients for adverse events as they would any patient with an authentic polypropylene surgical mesh implant, if they suspect or know that counterfeit mesh has been implanted.

Patients should contact their surgeon if they experience problems that they think may be related to surgical mesh.

The FDA continues to gather information and data on the counterfeit mesh to better understand its potential public health impact. The agency also is working to determine who may be responsible and how the counterfeiting and distribution occurred.

At this time, the FDA does not know if the counterfeit surgical mesh meets the authentic product’s specifications, including its strength, sterility, or clinical performance. The FDA assessment of the counterfeit mesh and its potential risk to health is ongoing.

Health care professionals who believe they have received counterfeit or suspect product are asked to contact the FDA’s Office of Criminal Investigations at 800-551-3989 or by visiting the Web site at http://www.fda.gov.OCI.

Prompt reporting of adverse events can help the FDA identify and better understand the risks associated with medical devices. If you suspect a problem with this or any counterfeit surgical mesh, the FDA encourages you to file a voluntary report through MedWatch, the FDA’s Safety Information and Adverse Event Reporting Program.

Health care professionals and consumers are encouraged to report serious adverse events (side effects) that may be related to the use of these counterfeit products to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail, fax or phone.

Online: www.fda.gov/MedWatch/report.htm
Regular Mail: use postage-paid, pre-addressed Form FDA 3500 available at: www.fda.gov/MedWatch/getforms.htm3. Mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
Fax: 800-FDA-0178
Phone: 800-332-1088

Health care providers employed by facilities that are subject to FDA's user facility reporting requirements should follow the reporting procedures established by their facilities.

For more information:

FDA’s Initial Communication: Safety Investigation of Counterfeit Polypropylene Surgical Mesh
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm203886.htm

Subscribe to our FREE Ezine and be eligible for Health News, discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com
We videotape Press Conferences, produce Satellite MediaTour's, B-rolls, PSA's, - all with distribution: HealthyTelevisionProductionstvmike13@healthnewsdigest.com



Top of Page

HealthNewsDigest.com

FDA Approval
Latest Headlines


+ FDA Issues Draft Guidance on Biosimilar Product Development
+ FDA and Industry Reach Agreement in Principle on Medical Device User Fees
+ FDA Warns About Unproven Stem Cell Claims
+ FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older
+ FDA Alerts Pharmacists and Health Care Professionals to Potential for Injury when Dispensing the Similar-Sounding Drugs Durezol and Durasal
+ FDA Targets Risks From Reused Medical Devices
+ Know Concentration Before Giving Acetaminophen to Infants
+ FDA Expands Use of HIV Drug Isentress to Children and Adolescents
+ Do Not Use ShoulderFlex Massagers
+ FDA Proposes Draft Guidelines Intended to Improve the Representation of Women in Medical Device Clinical Studies



Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions